Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions

Ovarian CancerBRCA Mutation

Trial Locations (1)

Abramson Cancer Center, Philadelphia

All Listed Sponsors

collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT06436248 - Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer | Biotech Hunter | Biotech Hunter